This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n15http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00064211%3A_____%2F09%3A%230000051%21RIV10-MZ0-00064211/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n16http://linked.opendata.cz/ontology/domain/vavai/
n12http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00064211%3A_____%2F09%3A%230000051%21RIV10-MZ0-00064211
rdf:type
n16:Vysledek skos:Concept
dcterms:description
The study compared the efficacy of a first-line treatment with alternating oral/intravenous vinorelbine versus docetaxel in a cisplatin-based combination in advanced non-small-cell lung cancer. Both arms provided similar efficacy in terms of response and QoL, with an acceptable tolerance profile. The study compared the efficacy of a first-line treatment with alternating oral/intravenous vinorelbine versus docetaxel in a cisplatin-based combination in advanced non-small-cell lung cancer. Both arms provided similar efficacy in terms of response and QoL, with an acceptable tolerance profile.
dcterms:title
Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer
skos:prefLabel
Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer
skos:notation
RIV/00064211:_____/09:#0000051!RIV10-MZ0-00064211
n3:aktivita
n14:V n14:Z
n3:aktivity
V, Z(MZ00000064211)
n3:cisloPeriodika
7
n3:dodaniDat
n9:2010
n3:domaciTvurceVysledku
n6:7693028
n3:druhVysledku
n17:J
n3:duvernostUdaju
n10:S
n3:entitaPredkladatele
n15:predkladatel
n3:idSjednocenehoVysledku
316467
n3:idVysledku
RIV/00064211:_____/09:#0000051
n3:jazykVysledku
n4:eng
n3:klicovaSlova
non-small cell lung cancer; vinorelbine oral; docetaxel; GLOB3
n3:klicoveSlovo
n8:GLOB3 n8:vinorelbine%20oral n8:non-small%20cell%20lung%20cancer n8:docetaxel
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[5C926EDE24FA]
n3:nazevZdroje
Annals of Oncology
n3:obor
n13:FC
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
11
n3:rokUplatneniVysledku
n9:2009
n3:svazekPeriodika
20
n3:tvurceVysledku
Rolski, J. Grodzki, T. Riska, H. Abratt, R. Aitini, E. Tsai, Y. H. Carteni, G. Gaizemeier, U. Petr, Zatloukal Tan, E. H. Schneider, C. P.
n3:wos
000267440500016
n3:zamer
n12:MZ00000064211
s:issn
0923-7534
s:numberOfPages
8